Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome.
Caspase-3 is a cysteine protease that is strongly implicated in neuronal apoptosis. Activation of caspase-3 may be induced by at least two major initiator pathways: a caspase-8-mediated pathway activated through cell surface death receptors (extrinsic pathway), and a caspase-9-mediated pathway activated by signals from the mitochondria that lead to formation of an apoptosomal complex (intrinsic pathway). In the present studies, we compare the activation of caspases-3, -8, and -9 after lateral fluid-percussion traumatic brain injury (TBI) in rats. Immunoblot analysis identified cleaved forms of caspases-3 and -9, but not caspase-8, at 1, 12, and 48 h after injury. Immunocytochemistry specific for cleaved caspases-3 and -9 revealed their expression primarily in neurons. These caspases were also frequently localized in TUNEL-positive cells, some of which demonstrated morphological features of apoptosis. However, caspases-3 and -9 were also found in neurons that were not TUNEL-positive, and other TUNEL-positive cells did not show activated caspases. In contrast to caspases-3 or -9, caspase-8 expression was only minimally changed by injury. An increase in expression of this caspase was undetectable by immunoblotting methods, and appeared as positive immunostaining restricted to a few cells within the injured cortex. Treatment with the pan-caspase inhibitor z-VAD-fmk at 15 min after TBI improved performance on motor and spatial learning tests. These data suggest that several caspases may be involved in the pathophysiology of TBI and that pan-caspase inhibition strategies may improve neurological outcomes.
Knoblach
Susan M
SM
Department of Neuroscience, Georgetown University, Washington, DC 20007, USA. knoblachs@giccs.georgetown.edu
Nikolaeva
Maria
M
Huang
Xiuling
X
Fan
Lei
L
Krajewski
Stanislaw
S
Reed
John C
JC
Faden
Alan I
AI
D000818:Animals; D000918:Antibody Specificity; D001921:Brain / Q000201:enzymology* / Q000473:pathology; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology; D020169:Caspases / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D053938:DNA Fragmentation; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D008928:Mitochondria / Q000201:enzymology; D009474:Neurons / Q000201:enzymology / Q000473:pathology; D051381:Rats; D020127:Recovery of Function
D020169:Caspases